Drug Profile
Research programme: anti-activated leukocyte cell adhesion molecule antibodies - Affitech A/S
Alternative Names: anti-ALCAM anitbody; anti-CD166 antibody; AT002 - Affitech; CBAS-173Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Affitech A/S
- Class Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Autoimmune disorders; Cancer; Inflammation
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Autoimmune-disorders in Norway (Parenteral)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in Norway (Parenteral)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Inflammation in Norway (Parenteral)